GSK non-GAAP EPS of 0.55 pounds beats by 0.04; revenue of 8.89 billion beats by 50 million
FROM THE WIRE · SEEKINGALPHA.COM
GSK Q3 earnings beat estimates on EPS and revenue, showing 4% yearly growth.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishBeats on both EPS and revenue, with 4% yearly growth and reaffirmed full-year guidance, support the shares.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Non-GAAP EPS was 0.55 pounds, beating estimates by 0.04 pounds.
- 02Revenue was 8.89 billion pounds, beating expectations by 50 million.
- 03Growth was 4% year on year and full-year guidance was reaffirmed.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets